ALNA News and Press, Allena Pharmaceuticals Inc. From 03/21/22

Late-stage biotech, Allena Pharmaceuticals (NASDAQ:ALNA), continues to trade lower with a decline of ~36% in the pre-market Monday after the company announced its decision to discontinue a Phase 3 trial for the lead candidate reloxaliase and highlighted its financial constraints. Following a ...

ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in serum uric acid and a well-tolerated safety profile in first cohort of patients with hyperuricemia and chronic kidney disease in the ...

NEWTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme therapeutics for difficult-to-treat metabol...

Allena Pharmaceuticals (NASDAQ:ALNA): Q3 GAAP EPS of -$0.17 beats by $0.01. Cash and cash equivalents of $40.42M. Press Release For further details see: Allena Pharmaceuticals EPS beats by $0.01

ALLN-346, a first-in-class, non-absorbed, orally administered enzyme in development for the treatment of hyperuricemia and gout in the setting of advanced chronic kidney disease, receives Fast Track Designation from FDA Two Phase 2a trials for ALLN-346 enrolling patients with go...

The Biotech space made a big move on Wednesday, sparking a rebirth in excitement about the space following the Federal Reserve’s move to start tapering its bond purchases. The move was expected to be a big hurdle for tech stocks, including biotechs. Instead, we got a melt-up, which inc...

FinancialBuzz.com’s latest The Buzz Show: Allena Pharmaceuticals, Inc (NASDAQ: ALNA) Receives Fast Track Designation from FDA for the Development of ALLN-346 ” Allena Pharmaceuticals, Inc  (NASDAQ: ALNA) surged over 20% in premarket t...

Are These Penny Stocks Worth Buying With AMC Stock By midday, a rally with meme stocks including AMC stock and GME stock, helped to shed light on penny stocks. At 10:30 AM EST shares of AMC Entertainment Holdings Inc. ( NYSE: AMC ) and GameStop Corp. ( NYSE: GME ) were up by ove...

Allena Pharmaceuticals (NASDAQ:ALNA) announces that its orally-administered, urate-degrading enzyme, ALLN-346, has received Fast Track designation from the U.S. FDA. Shares up more than 9% premarket. ALLN-346 is in Phase 2 development for the treatment of hyperuricemia in gout patie...

- Novel oral therapeutic candidate ALLN-346 targets uric acid in the intestinal tract - - Patients with gout and CKD have a serious condition with an unmet need for urate-lowering–therapies – -Two Phase 2a studies currently enrolling patients with hyperuricem...